share_log

6-K: Report of foreign private issuer (related to financial reporting)

6-K: Report of foreign private issuer (related to financial reporting)

6-K:外國發行人報告(業績相關)
美股SEC公告 ·  07/02 04:34

Moomoo AI 已提取核心訊息

TC BioPharm (Holdings) PLC, a foreign private issuer, filed a Form 6-K with the SEC for July 2024, indicating the indefinite adjournment of its first 2024 Annual General Meeting (AGM) due to insufficient quorum as per Nasdaq rules. The company, having satisfied UK quorum requirements, announced a second AGM scheduled for July 24, 2024, at its UK office. Shareholders of record as of July 22, 2024, are entitled to vote, with ADS holders voting by proxy before July 19, 2024. The agenda includes receiving the annual report, approving directors' remuneration, ratifying the appointment of Marcum LLP as the U.S. auditor, re-appointing Ecovis as the UK auditor, and authorizing the Audit Committee to determine auditor remuneration.
TC BioPharm (Holdings) PLC, a foreign private issuer, filed a Form 6-K with the SEC for July 2024, indicating the indefinite adjournment of its first 2024 Annual General Meeting (AGM) due to insufficient quorum as per Nasdaq rules. The company, having satisfied UK quorum requirements, announced a second AGM scheduled for July 24, 2024, at its UK office. Shareholders of record as of July 22, 2024, are entitled to vote, with ADS holders voting by proxy before July 19, 2024. The agenda includes receiving the annual report, approving directors' remuneration, ratifying the appointment of Marcum LLP as the U.S. auditor, re-appointing Ecovis as the UK auditor, and authorizing the Audit Committee to determine auditor remuneration.
外國私營發行人TC BioPharm (Holdings) PLC在2024年7月向美國證券交易委員會提交了一份6-K表格,指示其2024年首次股東大會因納斯達克規則的不足議決權而無限期休會。該公司已滿足英國的議決權要求,宣佈2024年7月24日在其英國辦事處舉行第二次股東大會。於2024年7月22日持股的股東有權投票,ADS持有人需要在2024年7月19日之前進行委託投票。會議議程包括審議年度報告,批准董事報酬,批准馬康姆LLP爲美國核數師,重新任命Ecovis爲英國核數師,並授權審計委員會判斷核數師報酬。
外國私營發行人TC BioPharm (Holdings) PLC在2024年7月向美國證券交易委員會提交了一份6-K表格,指示其2024年首次股東大會因納斯達克規則的不足議決權而無限期休會。該公司已滿足英國的議決權要求,宣佈2024年7月24日在其英國辦事處舉行第二次股東大會。於2024年7月22日持股的股東有權投票,ADS持有人需要在2024年7月19日之前進行委託投票。會議議程包括審議年度報告,批准董事報酬,批准馬康姆LLP爲美國核數師,重新任命Ecovis爲英國核數師,並授權審計委員會判斷核數師報酬。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息